Neumora Therapeutics Inc (NMRA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.1300 -0.0300 (-2.59%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.1300 unch (unch) 16:22 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | NMRA | TNGX | RZLT | ||
| Company | Neumora Therapeutics Inc | Tango Therapeutics Inc | Rezolute Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.1700 | 1.7500 | 3.05 | ||
| High | 1.1800 | 1.7900 | 3.14 | ||
| Low | 1.1150 | 1.6500 | 3.00 | ||
| Last | 1.1300 | 1.7600 | 3.05 | ||
| Change | -0.0300 | -0.0200 | -0.04 | ||
| % Change | -2.59% | -1.12% | -1.29% | ||
| Volume | 1,944,700 | 1,141,300 | 519,200 | ||
| 20-Day Average Volume | 1,313,010 | 848,170 | 521,240 | ||
| Previous Close | 1.1600 | 1.7800 | 3.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4020 | 1.9827 | 3.80 | ||
| 20-Day Raw Stochastic | 2.13% | 13.92% | 3.20% | ||
| 20-Day Relative Strength | 26.16% | 34.69% | 29.34% | ||
| Weighted Alpha | -68.40 | -78.71 | -13.93 | ||
| Today's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.72% since 03/14/25 | -9.74% since 03/14/25 | -15.28% since 03/14/25 | ||
| Low | 1.1150 on 03/21/25 | 1.6500 on 03/21/25 | 3.00 on 03/21/25 | ||
| High | 1.3095 on 03/17/25 | 2.0400 on 03/17/25 | 3.60 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -37.22% since 02/21/25 | -25.42% since 02/21/25 | -32.67% since 02/21/25 | ||
| Low | 1.1150 on 03/21/25 | 1.6500 on 03/21/25 | 3.00 on 03/21/25 | ||
| High | 1.8200 on 02/24/25 | 2.4400 on 02/26/25 | 4.56 on 02/24/25 | ||
| 3-Month | |||||
| %Chg | -89.59% since 12/20/24 | -43.23% since 12/20/24 | -30.52% since 12/20/24 | ||
| Low | 1.1150 on 03/21/25 | 1.6500 on 03/21/25 | 3.00 on 03/21/25 | ||
| High | 11.5700 on 12/27/24 | 3.6500 on 01/07/25 | 5.72 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | -91.25% since 09/20/24 | -78.80% since 09/20/24 | -39.96% since 09/20/24 | ||
| Low | 1.1150 on 03/21/25 | 1.6500 on 03/21/25 | 3.00 on 03/21/25 | ||
| High | 17.1874 on 10/18/24 | 8.4100 on 09/23/24 | 6.19 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 187,896 | 192,432 | 187,053 | ||
| Shares Outstanding, K | 161,979 | 108,108 | 60,535 | ||
| Annual Sales | 0 | 42,070,000 | 0 | ||
| Annual Net Income | -243,790,000 | -130,300,000 | -68,460,000 | ||
| Last Quarter Sales | 0 | 4,120,000 | 0 | ||
| Last Quarter Net Income | -58,820,000 | -37,670,000 | -15,730,000 | ||
| 60-Month Beta | 2.59 | 0.87 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 03/03/25 | -0.35 on 02/27/25 | -0.22 on 02/12/25 | ||
| Latest Earnings Date | 05/06/25 | 05/14/25 | 02/11/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||